Fibroblast growth factors as tissue repair and regeneration therapeutics

Quentin M. Nunes, Yong Li, Changye Sun, Tarja K. Kinnunen, David G. Fernig

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cell communication is central to the integration of cell function required for the development and homeostasis of multicellular animals. Proteins are an important currency of cell communication, acting locally (auto-, juxta-, or paracrine) or systemically (endocrine). The fibroblast growth factor (FGF) family contributes to the regulation of virtually all aspects of development and organogenesis, and after birth to tissue maintenance, as well as particular aspects of organism physiology. In the West, oncology has been the focus of translation of FGF research, whereas in China and to an extent Japan a major focus has been to use FGFs in repair and regeneration settings. These differences have their roots in research history and aims. The Chinese drive into biotechnology and the delivery of engineered clinical grade FGFs by a major Chinese research group were important enablers in this respect. The Chinese language clinical literature is not widely accessible. To put this into context, we provide the essential molecular and functional background to the FGF communication system covering FGF ligands, the heparan sulfate and Klotho co-receptors and FGF receptor (FGFR) tyrosine kinases. We then summarise a selection of clinical reports that demonstrate the efficacy of engineered recombinant FGF ligands in treating a wide range of conditions that require tissue repair/regeneration. Alongside, the functional reasons why application of exogenous FGF ligands does not lead to cancers are described. Together, this highlights that the FGF ligands represent a major opportunity for clinical translation that has been largely overlooked in the West.

Original languageEnglish
Article numbere1535
Number of pages31
JournalPeerJ
DOIs
Publication statusPublished - 12 Jan 2016

Fingerprint

fibroblast growth factors
Fibroblast Growth Factors
tissue repair
Regeneration
Repair
Tissue
therapeutics
Ligands
cell communication
Cell Communication
Therapeutics
translation (genetics)
Research
Fibroblast Growth Factor Receptors
Oncology
Heparitin Sulfate
Organogenesis
communications technology
Communication
Physiology

Cite this

Nunes, Quentin M. ; Li, Yong ; Sun, Changye ; Kinnunen, Tarja K. ; Fernig, David G. / Fibroblast growth factors as tissue repair and regeneration therapeutics. In: PeerJ. 2016.
@article{0756dd7d6c2b495c84ad9d70fb67de42,
title = "Fibroblast growth factors as tissue repair and regeneration therapeutics",
abstract = "Cell communication is central to the integration of cell function required for the development and homeostasis of multicellular animals. Proteins are an important currency of cell communication, acting locally (auto-, juxta-, or paracrine) or systemically (endocrine). The fibroblast growth factor (FGF) family contributes to the regulation of virtually all aspects of development and organogenesis, and after birth to tissue maintenance, as well as particular aspects of organism physiology. In the West, oncology has been the focus of translation of FGF research, whereas in China and to an extent Japan a major focus has been to use FGFs in repair and regeneration settings. These differences have their roots in research history and aims. The Chinese drive into biotechnology and the delivery of engineered clinical grade FGFs by a major Chinese research group were important enablers in this respect. The Chinese language clinical literature is not widely accessible. To put this into context, we provide the essential molecular and functional background to the FGF communication system covering FGF ligands, the heparan sulfate and Klotho co-receptors and FGF receptor (FGFR) tyrosine kinases. We then summarise a selection of clinical reports that demonstrate the efficacy of engineered recombinant FGF ligands in treating a wide range of conditions that require tissue repair/regeneration. Alongside, the functional reasons why application of exogenous FGF ligands does not lead to cancers are described. Together, this highlights that the FGF ligands represent a major opportunity for clinical translation that has been largely overlooked in the West.",
keywords = "Fibroblast growth factor, Fibroblast growth factor receptor, Healing, Heparan sulfate, Klotho, Protein therapeutic, Tissue repair, Ulcer, Wound",
author = "Nunes, {Quentin M.} and Yong Li and Changye Sun and Kinnunen, {Tarja K.} and Fernig, {David G.}",
year = "2016",
month = "1",
day = "12",
doi = "10.7717/peerj.1535",
language = "English",
journal = "PeerJ",
issn = "2167-8359",
publisher = "PeerJ",

}

Fibroblast growth factors as tissue repair and regeneration therapeutics. / Nunes, Quentin M.; Li, Yong; Sun, Changye; Kinnunen, Tarja K.; Fernig, David G.

In: PeerJ, 12.01.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fibroblast growth factors as tissue repair and regeneration therapeutics

AU - Nunes, Quentin M.

AU - Li, Yong

AU - Sun, Changye

AU - Kinnunen, Tarja K.

AU - Fernig, David G.

PY - 2016/1/12

Y1 - 2016/1/12

N2 - Cell communication is central to the integration of cell function required for the development and homeostasis of multicellular animals. Proteins are an important currency of cell communication, acting locally (auto-, juxta-, or paracrine) or systemically (endocrine). The fibroblast growth factor (FGF) family contributes to the regulation of virtually all aspects of development and organogenesis, and after birth to tissue maintenance, as well as particular aspects of organism physiology. In the West, oncology has been the focus of translation of FGF research, whereas in China and to an extent Japan a major focus has been to use FGFs in repair and regeneration settings. These differences have their roots in research history and aims. The Chinese drive into biotechnology and the delivery of engineered clinical grade FGFs by a major Chinese research group were important enablers in this respect. The Chinese language clinical literature is not widely accessible. To put this into context, we provide the essential molecular and functional background to the FGF communication system covering FGF ligands, the heparan sulfate and Klotho co-receptors and FGF receptor (FGFR) tyrosine kinases. We then summarise a selection of clinical reports that demonstrate the efficacy of engineered recombinant FGF ligands in treating a wide range of conditions that require tissue repair/regeneration. Alongside, the functional reasons why application of exogenous FGF ligands does not lead to cancers are described. Together, this highlights that the FGF ligands represent a major opportunity for clinical translation that has been largely overlooked in the West.

AB - Cell communication is central to the integration of cell function required for the development and homeostasis of multicellular animals. Proteins are an important currency of cell communication, acting locally (auto-, juxta-, or paracrine) or systemically (endocrine). The fibroblast growth factor (FGF) family contributes to the regulation of virtually all aspects of development and organogenesis, and after birth to tissue maintenance, as well as particular aspects of organism physiology. In the West, oncology has been the focus of translation of FGF research, whereas in China and to an extent Japan a major focus has been to use FGFs in repair and regeneration settings. These differences have their roots in research history and aims. The Chinese drive into biotechnology and the delivery of engineered clinical grade FGFs by a major Chinese research group were important enablers in this respect. The Chinese language clinical literature is not widely accessible. To put this into context, we provide the essential molecular and functional background to the FGF communication system covering FGF ligands, the heparan sulfate and Klotho co-receptors and FGF receptor (FGFR) tyrosine kinases. We then summarise a selection of clinical reports that demonstrate the efficacy of engineered recombinant FGF ligands in treating a wide range of conditions that require tissue repair/regeneration. Alongside, the functional reasons why application of exogenous FGF ligands does not lead to cancers are described. Together, this highlights that the FGF ligands represent a major opportunity for clinical translation that has been largely overlooked in the West.

KW - Fibroblast growth factor

KW - Fibroblast growth factor receptor

KW - Healing

KW - Heparan sulfate

KW - Klotho

KW - Protein therapeutic

KW - Tissue repair

KW - Ulcer

KW - Wound

UR - http://www.scopus.com/inward/record.url?scp=84955611988&partnerID=8YFLogxK

U2 - 10.7717/peerj.1535

DO - 10.7717/peerj.1535

M3 - Article

JO - PeerJ

JF - PeerJ

SN - 2167-8359

M1 - e1535

ER -